Stock market week-in-review for 5 large GI companies — Nov. 20-24

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Nov. 20 to Nov. 24, 2017.

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $174.92 on Nov. 20
Peaked: $176 on Nov. 22
Closed: $173.59 on Nov. 24
Percent change between Nov. 20 and Nov. 24: -0.76 percent

2. Exact Sciences Corp.

Opened: $58.87 on Nov. 20
Peaked: $59.97 on Nov. 21
Closed: $59.27 on Nov. 24
Percent change between Nov. 20 and Nov. 24: 0.67 percent

3. Johnson & Johnson

Opened: $137.98 on Nov. 20
Peaked: $139.24 on Nov. 21
Closed: $138.04 on Nov. 24
Percent change between Nov. 20 and Nov. 24: 0.04 percent

4. Synergy Pharmaceuticals

Opened: $1.95 on Nov. 20
Peaked at open
Closed: $1.90 on Nov. 24
Percent change between Nov. 20 and Nov. 24: -2.56 percent

5. Valeant Pharmaceuticals

Opened: $14.69 on Nov. 20
Peaked: $16.83 on Nov. 22
Closed: $16.56 on Nov. 24
Percent change between Nov. 20 and Nov. 24: 12.72 percent

More articles on gastroenterology: 
Preventable factors raise cancer risk in the US — 5 insights
SGS withdraws GI Dynamics' CE Mark & more — 6 GI company key notes
IQuilty introduces RNA-based blood test for IBS, IBD — 3 insights 

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months